WO2006079185A1 - Apparatus and method for monitoring cell motility - Google Patents

Apparatus and method for monitoring cell motility Download PDF

Info

Publication number
WO2006079185A1
WO2006079185A1 PCT/AU2006/000116 AU2006000116W WO2006079185A1 WO 2006079185 A1 WO2006079185 A1 WO 2006079185A1 AU 2006000116 W AU2006000116 W AU 2006000116W WO 2006079185 A1 WO2006079185 A1 WO 2006079185A1
Authority
WO
WIPO (PCT)
Prior art keywords
chemical agent
viewing surface
cell
chamber
aperture
Prior art date
Application number
PCT/AU2006/000116
Other languages
French (fr)
Inventor
Lilian Li Li Soon
John S. Condeelis
Original Assignee
The University Of Sydney
Albert Einstein College Of Medicine Of Yeshiva University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Sydney, Albert Einstein College Of Medicine Of Yeshiva University filed Critical The University Of Sydney
Priority to AU2006208430A priority Critical patent/AU2006208430A1/en
Publication of WO2006079185A1 publication Critical patent/WO2006079185A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502746Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B01L2200/027Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/08Regulating or influencing the flow resistance
    • B01L2400/084Passive control of flow resistance
    • B01L2400/086Passive control of flow resistance using baffles or other fixed flow obstructions

Definitions

  • Cell motility in response to a chemical agent is fundamentally important in many biological processes such as cancer metastasis , embryogenesis and wound healing .
  • the study of cell motility in response to specific chemical agents can lead to the identification of agents or receptors for the agents which are potential therapeutic targets for use in the treatment of wounds, cancer and inflammation .
  • cells capable of motility including bacteria, protozoa, amoeba, cellular slime moulds ( Dictyostelium discoideum) , fungi , sperm, fibroblasts , phagocytes , cancer cells , neurons , epithelial cells , endothelial cells , and cells of the immune system including mast cells , neutrophils , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils and basophils .
  • bacteria protozoa
  • amoeba cellular slime moulds
  • fungi fungi
  • sperm fibroblasts
  • phagocytes cancer cells
  • neurons neurons
  • epithelial cells endothelial cells
  • cells of the immune system including mast cells , neutrophils , lymphocytes , monocytes , macrophages , leukocytes , T-cells ,
  • neutrophils and Dictyostelium are typically fast moving and are able to maintain a direction of movement once determined even if concentrations of a chemical agent fluctuate .
  • cancer cells typically move 10-15 times slower than cells , such as neutrophils and Dictyostelium, and lack the ability to maintain a direction of movement and will often make numerous changes in direction of movement under conditions of fluctuating concentrations of the chemical agent .
  • the most informative way to study cell motility is through monitoring the motility cycle of a cell in response to a chemical agent of interest .
  • an apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
  • the apparatus may be used for monitoring any type of cell motility in response to a chemical agent .
  • Cell motility includes , but is not limited to chemotaxis , haptotaxis , chemokinesis , motility by contact priming (with substrate patterning) and invasion .
  • the term "chemical agent” as used herein refers to any type of agent to which a cell may respond .
  • the chemical agent may be synthetic, for example a drug or drug compound .
  • the chemical agent may be a biological factor, for example a sugar, amino acid, peptide or protein .
  • the chemical agent may be a chemoattractant and chemorepellent or a chemotactic agent .
  • the chamber of the apparatus may be made from any material suitable for monitoring cell motility in response to a chemical agent .
  • the chamber is made from an optically transparent material suitable for use with video microscopy .
  • the chamber may be made from glass or plastic .
  • the chamber can contain a medium suitable to monitoring cell motility .
  • the medium may be a liquid medium.
  • the medium may be a matrix .
  • the matrix is a gel .
  • the gel may comprise collagen, fibronectin, other connective tissue matrix components , other naturally-derived and tumour-derived matrix .
  • the medium may be a buffer such as MEM, DMEM, L15 , RPMI , HEPES-buffered medium.
  • the cells to be monitored are placed onto the cell viewing surface , with the cell viewing surface being arranged so as to be submersed in the medium.
  • the apparatus is suitable for monitoring any cell type .
  • Examples of cell types that may be monitored using the apparatus include but are not limited to cancer cells , spermatozoa, bacteria, fungi , epithelial cells , neurons , endothelial cells , fibroblasts , mast cells , neutrophils , dictyostelium cells , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils , basophils and combinations thereof .
  • the fluid delivery arrangement of the apparatus can be arranged in any configuration relative to the cell viewing surface provided that the configuration is suitable for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
  • the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
  • the one or each aperture can have a configuration that influences a direction to the flow of chemical agent through the aperture .
  • the side wall of the one or each aperture may influence a direction to the flow of chemical agent through the aperture .
  • the apertures may be located at any position relative to the cell viewing surface portion provided they are capable of releasing the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
  • the apertures may be located in the cell viewing surface .
  • the fluid delivery arrangement may further comprise a barrier construction arranged relative to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell viewing surface portion, the flow interacts with the barrier construction to impart the concentration gradient .
  • the barrier construction diverts the flow of chemical agent to impart the concentration gradient .
  • diverting the flow of chemical agent modulates any one or more of the following : the rate at which the gradient is formed; the steady-state shape of the gradient; the stability of the gradient; the steepness of the gradient .
  • the barrier can be defined by a physical means such as a dam.
  • the barrier can be defined by a photonic means such as through optical trapping . Methods for optical trapping and other photonic means are described in, for example, Dholakia and Reece ( 2006 ) Optical Micromanipulation Takes Hold, Nanotoday VoI 1 ( 1 ) : 18-27 ; Mach, P . et al .
  • the barrier can be defined by solid-phase chemistry as described in Lim et al . (2004 ) Retinal Pigment Epithelial Cell Behaviour is Modulated by Alterations in Focal Cell- Substrate Contacts , Investigative Ophthalmology & Visual Science , vol . 45 ( 11 ) : 42i ⁇ -4216 ) .
  • the cell viewing surface is a platform that defines a wall in the chamber, with the wall in turn defining the dam.
  • the wall may extend across the chamber from one chamber side to the other .
  • the fluid delivery arrangement of the apparatus may further comprise one or more conduits in fluid communication with a source for the chemical agent, one or each conduit extending to one or each respective aperture .
  • the conduits are one or more channels in a substrate that each extend to a respective aperture positioned in, or in relation to, the substrate .
  • the channels can be any dimension suitable for delivery of the chemical agent to the cell viewing surface portion .
  • the channels can be as deep as the depth of view of the lowest magnification obj ective lenses and as wide as the width of the chamber .
  • the channels are 50 ⁇ m in depth and 50 ⁇ m in width .
  • the one or each conduit is defined by a respective one or more micropipettes , with each aperture being defined by an outlet of the respective micropipette .
  • the apertures of the apparatus may be any size suitable for directing the chemical agent such that , when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
  • the apertures can be as wide as the width of the chamber and as narrow as 0.02 ⁇ m. In one embodiment , the apertures are l ⁇ m in diameter .
  • the chemical agent may be delivered to the cell viewing surface portion under pressure .
  • the chemical agent may be delivered at a constant and continuous pressure .
  • the chemical agent may be delivered under pulsed pressure .
  • the chemical agent - may be delivered at any pressure that is suitable for delivering the chemical agent .
  • the chemical agent when the chemical agent is delivered at 0 hPa constant pressure, the chemical may diffuse freely into the medium in the chamber .
  • the chemical ⁇ agent is delivered at 0 hPa pulsed pressure, backpressure or pressure less than 0 hPa may be applied to stop the flow of chemical agent at intervals .
  • the chemical agent is delivered at a pressure of 0 hPa or more .
  • the chemical agent is delivered at a pressure of 2OhPa .
  • apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface , the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery arrangement to the cell viewing surface portion, the flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium.
  • the barrier construction of the second aspect may be defined by the aperture wall ( s ) or dam of the first aspect .
  • the apparatus of the second aspect may otherwise be as defined as per the first aspect .
  • a method for monitoring cell motility in response to a chemical agent in a medium comprising the step of delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells , the chemical agent has assumed a concentration gradient in the medium.
  • the concentration gradient of the chemical agent can be shaped by physically directing the flow of chemical agent to the medium in the vicinity of the one or more cells .
  • the flow of the chemical agent is directed through one or more apertures arranged in the medium.
  • a side wall of one or each aperture may physically direct the flow of the chemical agent through the aperture .
  • the flow of chemical agent interacts with a barrier arranged in the fluid medium to physically direct the flow of the chemical agent .
  • the barrier can be defined by a dam.
  • the method for monitoring cell motility may be performed using the apparatus as described in the first and second aspects .
  • Figure IA shows a perspective view of one form of the apparatus for monitoring cell motility employing a single micropipette ;
  • Figure IB shows a side sectional view of the apparatus shown in Figure IA;
  • Figure 2A shows a perspective view of the apparatus shown in Figure 1 employing multiple micropipettes 2a;
  • Figure 2B shows a perspective view of the apparatus shown in Figure 1 employing a micropipette 2a having a broad tip
  • Figure 3 shows a perspective view of another form of the apparatus for monitoring cell motility in which :
  • Figure 3A shows a perspective view of an upper substrate 1 containing apertures Ia
  • Figure 3B shows a perspective view of a lower substrate 2 containing channels 2a;
  • Figure 3C shows a perspective view of the assembled product of surfaces 1 and 2 , with superimposition of the substrates and the upper apertures Ia and lower channels 2a;
  • Figure 3D shows an enlarged sectional view of the apparatus shown in Figure 3C showing the relative positions of a single aperture Ia in the upper substrate 1 , and the opening 2b of the channel 2a in the lower substrate 2 ;
  • Figure 3E shows an enlarged view of a single aperture of the upper substrate shown in Figure 3A, where the side walls of the aperture direct the flow of chemical agent (the concentration gradient 7 forms at the rim of the aperture and its direction is generally- perpendicular to the vertical flow along the walls of aperture Ib) ;
  • Figure 3F shows various alternative embodiments for the configuration of aperture Ia
  • Figure 3G shows a perspective view of the apparatus shown in Figure 3C incorporating a single elongate aperture ;
  • Figure 3H shows a perspective view of the apparatus shown in Figure 3C in which the alignment of the aperture ( s ) is intermediate the channel ( s ) and not at the channel termini , and where the termini of the channel ( s ) are sealed; and with additional aperture set ( s ) being provided along the length of the channel ;
  • Figure 4 shows various embodiments of the apparatus shown in Figure 3 in which : Figure 4A depicts a single channel;
  • Figure 4B depicts more than one channel
  • Figure 4C depicts more than one channel 2a, each housed in a sub-chamber 3 ;
  • Figure 4D depicts groups of more than one channel in a single sub-chamber 3 ;
  • Figure 4E depicts groups of channels where each group is housed in its own sub-chamber 3 ;
  • Figure 5 shows a perspective view of another form of the apparatus for monitoring cell motility
  • Figure 6 shows a plan view of yet another form of the apparatus for monitoring cell motility
  • Figure 7 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figures 1 and 2
  • Figure 8 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figure 3 ;
  • Figure 9 shows the concentration gradient of a chemical agent at various pressures .
  • FIG. 1 , 2 and 7 one embodiment of an apparatus for monitoring cell motility is shown .
  • This embodiment is typically employed for monitoring slow moving cell types , such as cancer cells .
  • the apparatus shown comprises a chamber 3 housing two optically-transparent substrates , an upper cell viewing substrate 1 and lower substrate 2 forming a floor of the chamber 3.
  • the substrates are approximately 100 microns in thickness ( t ) .
  • the substrates 1 , 2 are bonded together either permanently or non-permanently to form a sealed unit .
  • the wall Ia of the cell viewing surface 1 defines a dam extending across the chamber from one side to the other .
  • One or more micropipettes 2a extend to an aperture in the form of a distal outlet of the micropipette, which in use is positioned to abut the dam Ia .
  • the outlet diameter of the micropipette is typically 0.5 ⁇ m.
  • each micropipette can also be held in place against dam wall Ia via a suitable adj ustable j ig .
  • the cells to be monitored are seeded onto an upper surface of the cell viewing substrate 1 , and the chamber filled with a suitable buffer .
  • the micropipette ( s ) 2a is filled with a chemical agent and then positioned at a 40° angle ( ⁇ ) to the dam Ia .
  • the 40° angle has been found to be optimal for concentration gradient generation in the apparatus depicted, but of course can and may vary with chamber variation .
  • the micropipette ( s ) is lowered into the chamber 3 , manoeuvred onto the upper surface of the cell viewing substrate 1 , drawn over the edge, lowered to a distance (H) of 17 ⁇ m from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall Ia .
  • H a distance of 17 ⁇ m from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall Ia .
  • the micropipette ( s ) are then connected to a compressor (not shown) , for example a Femtoj et micromanipulator 5171 (Eppendorf) compressor .
  • the compressor produces an adj ustable, continuous pressure ( P) of approximately 20 hPa .
  • P adj ustable, continuous pressure
  • This pressure induces the flow of the chemical agent through and out of the micropipette 2a .
  • the flow of agent in the medium reaches the top edge of the cell viewing substrate 1 and, as it progresses over the edge, it has imparted thereto via the wall Ia and the wall edge a concentration gradient of chemical agent , which advances into the portion of the upper surface of the cell viewing substrate 1 where the cells are located .
  • the position of the micropipette 2a and the pressure at which the chemical agent is delivered as described above result in a flow of chemical agent , and a moving gradient of concentration of the agent , which is generally perpendicular to the path of the moving cells on the surface of the cell viewing substrate .
  • the concentration gradient that forms has two phases ( Figure 7 ) .
  • the first phase spans the 17 ⁇ m distance from the tip of the micropipette 2a to the upper surface of the cell viewing substrate 1. This phase typically has a high diffusion rate .
  • the second phase spans from the edge of cell viewing substrate 1 across the upper surface of the cell viewing substrate 1.
  • This phase typically has a slower diffusion rate .
  • the dam wall Ia provides for the rapid establishment of a stable and steep gradient , typically within 20 seconds of micropipette agent release, that results in a slow rate of diffusion of growth factors across the upper surface of the cell viewing substrate .
  • the cell motility is typically then monitored by time-lapse video microscopy for approximately 1 hour .
  • the apparatus shown in Figures 1 and 2 may be used with a single micropipette as shown in Figures IA and IB, with multiple micropipettes as shown in Figure 2A, or with a broad tipped pipette as shown in Figure 2B .
  • One advantage of using multiple micropipettes or a broad tipped pipette is the resultant increase in the area of the concentration gradient that the cells are exposed to . This increases the number of cells that can be monitored, and therefore, the throughput of an experiment .
  • FIG. 3 , 4 and 8 where like reference numerals are used to denote similar or like parts , another embodiment of the apparatus for monitoring cell motility is shown .
  • This form is typically suitable for monitoring slow moving cell types , such as cancer cells .
  • the apparatus shown comprises a chamber 3 with two optically-transparent substrates , an upper cell viewing substrate 1 , as shown in Figure 3A and a lower substrate 2 as shown in Figure 3B .
  • the substrates are microfabricated to contain either apertures Ia or channels 2a .
  • the substrates are then bonded together either permanently or non-permanently to form a sealed unit as shown Figure 3C .
  • the cell viewing substrate 1 serves as a cover and to enclose the channels 2a .
  • the cell viewing substrate 1 contains apertures Ia that overlay the termini of the channels 2a in the lower substrate .
  • the channels 2a are connected to an inlet 6, which connects to a compressor (not shown) and allows the delivery of a chemical agent to the cell viewing substrate 1 ( Figures 3A and 3C) .
  • Figure 3D shows a detailed view of the relationship between an aperture Ia in the cell viewing substrate and the opening 2b of a channel 2a in the lower substrate that combine to direct the chemical agent to the upper surface of the cell viewing substrate 1.
  • the side wall of an aperture causes the flow of the chemical agent through the aperture to form a concentration gradient 7 which then fans over the top edge of the aperture as shown in Figure 3E .
  • Figure 8 shows the concentration profile of a chemical agent obtained using the apparatus as shown in Figure 3.
  • the apertures Ia and the termini of the channels 2a may be provided with various shapes , several examples of which are shown in Figure 3F .
  • Figure 3G shows an embodiment in which the aperture Ia is provided in the form of an elongate groove within the cell viewing substrate 1.
  • the aperture ( s ) Ia can be positioned at more than one location along and in the cell viewing substrate relative to the channels 2a as shown in Figure 3H .
  • Figure 4 depicts alternative configurations for the apparatus , including Figure 4A : a single channel 2a within a single chamber 3 ; Figure 4B : multiple channels 2a within a single chamber 3 ; Figure 4C : multiple channels 2a within individual sub- chambers 3 ; Figure 4D : groups of two or more channels 2a within a single sub-chamber 3 ; and Figure 4E : groups of two or more channels 2a within individual sub-chambers 3.
  • Figure 5 shows another embodiment of the apparatus for monitoring cell motility .
  • Figure 5C shows the assembled apparatus .
  • Figure 5A shows an upper substrate 1 supporting a chamber 3 thereover, and with apertures Ia formed in the substrate .
  • Figure 5B shows a lower substrate 2 with channels 2a defined therein .
  • the termini 2b of the channels 2a in this embodiment are triangular in shape
  • the apertures Ia are l ⁇ m in diameter .
  • the channels can vary from l ⁇ m x l ⁇ m up to 50 ⁇ m x 50 ⁇ m in size without effecting the concentration profile .
  • the apertures are spaced on the cell viewing substrate 1 at least 40 ⁇ m apart, for embodiments where the channels 2a are 50 ⁇ m x 50 ⁇ m in size .
  • Figure 6 shows another embodiment of the apparatus in which the chamber 3 is circular in shape and the inlet 6 from the chemical agent is located in the centre .
  • the apertures Ia are located around the periphery of the chamber 3 with radially extending channels 2a extending to each respective aperture Ia from inlet 6.
  • Figure 7 shows the steady state concentration profile of a chemical agent formed by diverting the flow of chemical agent using a barrier as described in above and in Figures 1 and 2.
  • dam Ia diverts the flow of chemical agent from micropippette 2a to impart a concentration gradient .
  • the rate of formation of the gradient, the shape and steepness of the gradient, and/or the stability of the gradient can be modulated .
  • Figure 9 shows the concentration profile of a chemical agent as it varies with pressure .
  • the Figure indicates that at pressures ranging from 10 , 000 to 400 , 000 Nm "2 the concentration gradient of the chemical agent remains steep, dropping from a concentration of 0.000001M to OM over a 40 ⁇ m distance .

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Clinical Laboratory Science (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

An apparatus for monitoring cell motility in response to a chemical agent comprises a chamber for containing a medium and a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use. A fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface is arranged, relative to the cell viewing surface portion, for directing the chemical agent such that when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion.

Description

Apparatus and Method for Monitoring Cell Motility
Technical Field
Disclosed is an apparatus and method for monitoring cell motility in response to a chemical agent .
Background
Cell motility in response to a chemical agent is fundamentally important in many biological processes such as cancer metastasis , embryogenesis and wound healing . The study of cell motility in response to specific chemical agents can lead to the identification of agents or receptors for the agents which are potential therapeutic targets for use in the treatment of wounds, cancer and inflammation .
For a cell to become motile there are discrete steps of detection of a chemical agent, protrusion, adhesion of the protrusion to a substrate , the release of adhesion at the posterior of the cell and contraction that pulls the cell forward into the protrusion .
There are many types of cells capable of motility including bacteria, protozoa, amoeba, cellular slime moulds ( Dictyostelium discoideum) , fungi , sperm, fibroblasts , phagocytes , cancer cells , neurons , epithelial cells , endothelial cells , and cells of the immune system including mast cells , neutrophils , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils and basophils .
The different cell types demonstrate variations in motility . For example , neutrophils and Dictyostelium are typically fast moving and are able to maintain a direction of movement once determined even if concentrations of a chemical agent fluctuate . In contrast, cancer cells typically move 10-15 times slower than cells , such as neutrophils and Dictyostelium, and lack the ability to maintain a direction of movement and will often make numerous changes in direction of movement under conditions of fluctuating concentrations of the chemical agent .
The most informative way to study cell motility is through monitoring the motility cycle of a cell in response to a chemical agent of interest .
However, the currently available methods and apparatus for monitoring cell motility are only suitable for certain cell types such as fast moving neutrophils or leukocytes and are not adaptable for other cell types such as slow moving cancer cells .
Summary
In one aspect, there is provided an apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion . The apparatus may be used for monitoring any type of cell motility in response to a chemical agent . Cell motility includes , but is not limited to chemotaxis , haptotaxis , chemokinesis , motility by contact priming (with substrate patterning) and invasion .
The term "chemical agent" as used herein refers to any type of agent to which a cell may respond . The chemical agent may be synthetic, for example a drug or drug compound . The chemical agent may be a biological factor, for example a sugar, amino acid, peptide or protein . The chemical agent may be a chemoattractant and chemorepellent or a chemotactic agent .
The chamber of the apparatus may be made from any material suitable for monitoring cell motility in response to a chemical agent . In one form the chamber is made from an optically transparent material suitable for use with video microscopy . For example, the chamber may be made from glass or plastic .
In use, the chamber can contain a medium suitable to monitoring cell motility . The medium may be a liquid medium. The medium may be a matrix . In one form the matrix is a gel . The gel may comprise collagen, fibronectin, other connective tissue matrix components , other naturally-derived and tumour-derived matrix . The medium may be a buffer such as MEM, DMEM, L15 , RPMI , HEPES-buffered medium.
In use , the cells to be monitored are placed onto the cell viewing surface , with the cell viewing surface being arranged so as to be submersed in the medium. The apparatus is suitable for monitoring any cell type .
Examples of cell types that may be monitored using the apparatus include but are not limited to cancer cells , spermatozoa, bacteria, fungi , epithelial cells , neurons , endothelial cells , fibroblasts , mast cells , neutrophils , dictyostelium cells , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils , basophils and combinations thereof .
The fluid delivery arrangement of the apparatus can be arranged in any configuration relative to the cell viewing surface provided that the configuration is suitable for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
In one form, the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion . In this form, the one or each aperture can have a configuration that influences a direction to the flow of chemical agent through the aperture . For example , the side wall of the one or each aperture may influence a direction to the flow of chemical agent through the aperture .
The apertures may be located at any position relative to the cell viewing surface portion provided they are capable of releasing the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion . For example , the apertures may be located in the cell viewing surface .
In another form, the fluid delivery arrangement may further comprise a barrier construction arranged relative to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell viewing surface portion, the flow interacts with the barrier construction to impart the concentration gradient .
In one form, the barrier construction diverts the flow of chemical agent to impart the concentration gradient . Typically, diverting the flow of chemical agent modulates any one or more of the following : the rate at which the gradient is formed; the steady-state shape of the gradient; the stability of the gradient; the steepness of the gradient . The barrier can be defined by a physical means such as a dam. The barrier can be defined by a photonic means such as through optical trapping . Methods for optical trapping and other photonic means are described in, for example, Dholakia and Reece ( 2006 ) Optical Micromanipulation Takes Hold, Nanotoday VoI 1 ( 1 ) : 18-27 ; Mach, P . et al . ( 2002 ) Tunable microfluidic optical fiber, Applied Physics Letters , vol . 80 ( 23 ) : 4294-4296. The barrier can be defined by solid-phase chemistry as described in Lim et al . (2004 ) Retinal Pigment Epithelial Cell Behaviour is Modulated by Alterations in Focal Cell- Substrate Contacts , Investigative Ophthalmology & Visual Science , vol . 45 ( 11 ) : 42iθ-4216 ) .
In one embodiment, the cell viewing surface is a platform that defines a wall in the chamber, with the wall in turn defining the dam. The wall may extend across the chamber from one chamber side to the other .
The fluid delivery arrangement of the apparatus may further comprise one or more conduits in fluid communication with a source for the chemical agent, one or each conduit extending to one or each respective aperture .
In one embodiment, the conduits are one or more channels in a substrate that each extend to a respective aperture positioned in, or in relation to, the substrate . The channels can be any dimension suitable for delivery of the chemical agent to the cell viewing surface portion . For example , the channels can be as deep as the depth of view of the lowest magnification obj ective lenses and as wide as the width of the chamber . In one embodiment, the channels are 50μm in depth and 50μm in width .
In another embodiment, the one or each conduit is defined by a respective one or more micropipettes , with each aperture being defined by an outlet of the respective micropipette .
The apertures of the apparatus may be any size suitable for directing the chemical agent such that , when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion . The apertures can be as wide as the width of the chamber and as narrow as 0.02μm. In one embodiment , the apertures are lμm in diameter .
The chemical agent may be delivered to the cell viewing surface portion under pressure . The chemical agent may be delivered at a constant and continuous pressure . Alternatively, the chemical agent may be delivered under pulsed pressure . The chemical agent - may be delivered at any pressure that is suitable for delivering the chemical agent . For example, when the chemical agent is delivered at 0 hPa constant pressure, the chemical may diffuse freely into the medium in the chamber . When the chemical ■agent is delivered at 0 hPa pulsed pressure, backpressure or pressure less than 0 hPa may be applied to stop the flow of chemical agent at intervals . Typically, the chemical agent is delivered at a pressure of 0 hPa or more . In one embodiment, the chemical agent is delivered at a pressure of 2OhPa .
In a second aspect, there is provided apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface , the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery arrangement to the cell viewing surface portion, the flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium.
The barrier construction of the second aspect may be defined by the aperture wall ( s ) or dam of the first aspect . The apparatus of the second aspect may otherwise be as defined as per the first aspect .
In a third aspect , there is provided a method for monitoring cell motility in response to a chemical agent in a medium, comprising the step of delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells , the chemical agent has assumed a concentration gradient in the medium. The concentration gradient of the chemical agent can be shaped by physically directing the flow of chemical agent to the medium in the vicinity of the one or more cells .
In one form, the flow of the chemical agent is directed through one or more apertures arranged in the medium. A side wall of one or each aperture may physically direct the flow of the chemical agent through the aperture .
In another form, the flow of chemical agent interacts with a barrier arranged in the fluid medium to physically direct the flow of the chemical agent . The barrier can be defined by a dam.
The method for monitoring cell motility may be performed using the apparatus as described in the first and second aspects .
Brief Description of Drawings
Notwithstanding any other forms that may fall within the scope of the method and apparatus as defined in the Summary, specific embodiments of the method and apparatus will now be described, by way of example only, with reference to the accompanying drawings in which :
Figure IA shows a perspective view of one form of the apparatus for monitoring cell motility employing a single micropipette ;
Figure IB shows a side sectional view of the apparatus shown in Figure IA;
Figure 2A shows a perspective view of the apparatus shown in Figure 1 employing multiple micropipettes 2a;
Figure 2B shows a perspective view of the apparatus shown in Figure 1 employing a micropipette 2a having a broad tip; Figure 3 shows a perspective view of another form of the apparatus for monitoring cell motility in which :
Figure 3A shows a perspective view of an upper substrate 1 containing apertures Ia; Figure 3B shows a perspective view of a lower substrate 2 containing channels 2a;
Figure 3C shows a perspective view of the assembled product of surfaces 1 and 2 , with superimposition of the substrates and the upper apertures Ia and lower channels 2a;
Figure 3D shows an enlarged sectional view of the apparatus shown in Figure 3C showing the relative positions of a single aperture Ia in the upper substrate 1 , and the opening 2b of the channel 2a in the lower substrate 2 ;
Figure 3E shows an enlarged view of a single aperture of the upper substrate shown in Figure 3A, where the side walls of the aperture direct the flow of chemical agent (the concentration gradient 7 forms at the rim of the aperture and its direction is generally- perpendicular to the vertical flow along the walls of aperture Ib) ;
Figure 3F shows various alternative embodiments for the configuration of aperture Ia; Figure 3G shows a perspective view of the apparatus shown in Figure 3C incorporating a single elongate aperture ;
Figure 3H shows a perspective view of the apparatus shown in Figure 3C in which the alignment of the aperture ( s ) is intermediate the channel ( s ) and not at the channel termini , and where the termini of the channel ( s ) are sealed; and with additional aperture set ( s ) being provided along the length of the channel ;
Figure 4 shows various embodiments of the apparatus shown in Figure 3 in which : Figure 4A depicts a single channel;
Figure 4B depicts more than one channel ;
Figure 4C depicts more than one channel 2a, each housed in a sub-chamber 3 ;
Figure 4D depicts groups of more than one channel in a single sub-chamber 3 ; and
Figure 4E depicts groups of channels where each group is housed in its own sub-chamber 3 ;
Figure 5 shows a perspective view of another form of the apparatus for monitoring cell motility; Figure 6 shows a plan view of yet another form of the apparatus for monitoring cell motility;
Figure 7 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figures 1 and 2 ; Figure 8 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figure 3 ; and
Figure 9 shows the concentration gradient of a chemical agent at various pressures .
Detailed Description of Specific Embodiments
Referring firstly to Figures 1 , 2 and 7 , one embodiment of an apparatus for monitoring cell motility is shown . This embodiment is typically employed for monitoring slow moving cell types , such as cancer cells . The apparatus shown comprises a chamber 3 housing two optically-transparent substrates , an upper cell viewing substrate 1 and lower substrate 2 forming a floor of the chamber 3. The substrates are approximately 100 microns in thickness ( t ) . The substrates 1 , 2 are bonded together either permanently or non-permanently to form a sealed unit . The wall Ia of the cell viewing surface 1 defines a dam extending across the chamber from one side to the other . One or more micropipettes 2a extend to an aperture in the form of a distal outlet of the micropipette, which in use is positioned to abut the dam Ia . The outlet diameter of the micropipette is typically 0.5μm.
The aperture of each micropipette can also be held in place against dam wall Ia via a suitable adj ustable j ig . In use , the cells to be monitored are seeded onto an upper surface of the cell viewing substrate 1 , and the chamber filled with a suitable buffer . The micropipette ( s ) 2a is filled with a chemical agent and then positioned at a 40° angle (θ) to the dam Ia . The 40° angle has been found to be optimal for concentration gradient generation in the apparatus depicted, but of course can and may vary with chamber variation . The micropipette ( s ) is lowered into the chamber 3 , manoeuvred onto the upper surface of the cell viewing substrate 1 , drawn over the edge, lowered to a distance (H) of 17μm from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall Ia . Again, the 17μm distance has been found to be optimal , but can vary .
The micropipette ( s ) are then connected to a compressor (not shown) , for example a Femtoj et micromanipulator 5171 (Eppendorf) compressor . The compressor produces an adj ustable, continuous pressure ( P) of approximately 20 hPa . This pressure induces the flow of the chemical agent through and out of the micropipette 2a . After leaving the micropipette the flow of agent in the medium reaches the top edge of the cell viewing substrate 1 and, as it progresses over the edge, it has imparted thereto via the wall Ia and the wall edge a concentration gradient of chemical agent , which advances into the portion of the upper surface of the cell viewing substrate 1 where the cells are located . The position of the micropipette 2a and the pressure at which the chemical agent is delivered as described above result in a flow of chemical agent , and a moving gradient of concentration of the agent , which is generally perpendicular to the path of the moving cells on the surface of the cell viewing substrate . The concentration gradient that forms has two phases ( Figure 7 ) . The first phase spans the 17μm distance from the tip of the micropipette 2a to the upper surface of the cell viewing substrate 1. This phase typically has a high diffusion rate . The second phase spans from the edge of cell viewing substrate 1 across the upper surface of the cell viewing substrate 1. This phase typically has a slower diffusion rate . Thus the dam wall Ia provides for the rapid establishment of a stable and steep gradient , typically within 20 seconds of micropipette agent release, that results in a slow rate of diffusion of growth factors across the upper surface of the cell viewing substrate .
The cell motility is typically then monitored by time-lapse video microscopy for approximately 1 hour . The apparatus shown in Figures 1 and 2 may be used with a single micropipette as shown in Figures IA and IB, with multiple micropipettes as shown in Figure 2A, or with a broad tipped pipette as shown in Figure 2B . One advantage of using multiple micropipettes or a broad tipped pipette is the resultant increase in the area of the concentration gradient that the cells are exposed to . This increases the number of cells that can be monitored, and therefore, the throughput of an experiment .
Referring now to Figures 3 , 4 and 8 , where like reference numerals are used to denote similar or like parts , another embodiment of the apparatus for monitoring cell motility is shown . This form is typically suitable for monitoring slow moving cell types , such as cancer cells .
The apparatus shown comprises a chamber 3 with two optically-transparent substrates , an upper cell viewing substrate 1 , as shown in Figure 3A and a lower substrate 2 as shown in Figure 3B . The substrates are microfabricated to contain either apertures Ia or channels 2a .
The substrates are then bonded together either permanently or non-permanently to form a sealed unit as shown Figure 3C . Once sealed, the cell viewing substrate 1 serves as a cover and to enclose the channels 2a . The cell viewing substrate 1 contains apertures Ia that overlay the termini of the channels 2a in the lower substrate .
The channels 2a are connected to an inlet 6, which connects to a compressor (not shown) and allows the delivery of a chemical agent to the cell viewing substrate 1 ( Figures 3A and 3C) .
Figure 3D shows a detailed view of the relationship between an aperture Ia in the cell viewing substrate and the opening 2b of a channel 2a in the lower substrate that combine to direct the chemical agent to the upper surface of the cell viewing substrate 1. The side wall of an aperture causes the flow of the chemical agent through the aperture to form a concentration gradient 7 which then fans over the top edge of the aperture as shown in Figure 3E . Figure 8 shows the concentration profile of a chemical agent obtained using the apparatus as shown in Figure 3.
The apertures Ia and the termini of the channels 2a may be provided with various shapes , several examples of which are shown in Figure 3F . Figure 3G shows an embodiment in which the aperture Ia is provided in the form of an elongate groove within the cell viewing substrate 1. The aperture ( s ) Ia can be positioned at more than one location along and in the cell viewing substrate relative to the channels 2a as shown in Figure 3H .
The apparatus shown in Figure 3 can be modified to accommodate high-throughput experiments . Figure 4 depicts alternative configurations for the apparatus , including Figure 4A : a single channel 2a within a single chamber 3 ; Figure 4B : multiple channels 2a within a single chamber 3 ; Figure 4C : multiple channels 2a within individual sub- chambers 3 ; Figure 4D : groups of two or more channels 2a within a single sub-chamber 3 ; and Figure 4E : groups of two or more channels 2a within individual sub-chambers 3.
Figure 5 shows another embodiment of the apparatus for monitoring cell motility . Figure 5C shows the assembled apparatus .
Figure 5A shows an upper substrate 1 supporting a chamber 3 thereover, and with apertures Ia formed in the substrate . Figure 5B shows a lower substrate 2 with channels 2a defined therein . The termini 2b of the channels 2a in this embodiment are triangular in shape
(but could be any shape ) , and are 50μm wide and 50μm deep . The apertures Ia are lμm in diameter . The channels can vary from lμm x lμm up to 50μm x 50μm in size without effecting the concentration profile . However, to avoid interaction between flow from each aperture Ia, the apertures are spaced on the cell viewing substrate 1 at least 40μm apart, for embodiments where the channels 2a are 50μm x 50μm in size .
Figure 6 shows another embodiment of the apparatus in which the chamber 3 is circular in shape and the inlet 6 from the chemical agent is located in the centre . The apertures Ia are located around the periphery of the chamber 3 with radially extending channels 2a extending to each respective aperture Ia from inlet 6.
Figure 7 shows the steady state concentration profile of a chemical agent formed by diverting the flow of chemical agent using a barrier as described in above and in Figures 1 and 2. As can be seen from Figure 7 , dam Ia diverts the flow of chemical agent from micropippette 2a to impart a concentration gradient . By diverting the flow of chemical agent , the rate of formation of the gradient, the shape and steepness of the gradient, and/or the stability of the gradient can be modulated .
Figure 9 shows the concentration profile of a chemical agent as it varies with pressure . The Figure indicates that at pressures ranging from 10 , 000 to 400 , 000 Nm"2 the concentration gradient of the chemical agent remains steep, dropping from a concentration of 0.000001M to OM over a 40 μm distance .
It will be apparent to a person skilled in the art that while the method and apparatus have been described herein in some detail for the purposes of clarity and understanding, various modifications and alterations to the embodiments described herein may be made without departing from the scope of concept disclosed in this specification .
In the claims which follow and in the preceding description, except where the context requires otherwise due to express language or necessary implication, "comprise" and variations such as "comprises" or "comprising" are used in an inclusive sense (i . e . to specify the presence of the stated features but not to preclude the presence or addition of further features ) . It is understood that a reference herein to a prior art document does not constitute an admission that the document forms part of the common general knowledge in the art in Australia or any other country .

Claims

CLAIMS :
1. Apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use ; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface ; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
2. Apparatus according to claim 1 , wherein the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
3. Apparatus according to claim 2 , wherein the one or each aperture has a configuration that influences a direction to the flow of chemical agent through the aperture .
4. Apparatus according to claim 3 , wherein the side wall of the one or each aperture influences a direction to the flow of chemical agent through the aperture .
5. Apparatus according to claim 4 , wherein the apertures are located in the cell viewing surface .
6. Apparatus according to claim 2 , wherein the fluid delivery arrangement further comprises a barrier construction arranged relative to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell viewing surface portion, the flow interacts with the barrier construction to impart the concentration gradient .
7. Apparatus according to claim 6, wherein the barrier is defined by a physical means .
8. Apparatus according to claim 7 , wherein the physical means is a dam.
9. Apparatus according to claim 6, wherein the barrier is defined by a photonic means .
10. Apparatus according to claims 6 , wherein the barrier is defined by solid-state chemistry .
11. Apparatus according to claim 8 , wherein the cell viewing surface is a platform that defines a wall in the chamber, with the wall in turn defining the dam.
12. Apparatus according to claim 11 , wherein the wall extends across the chamber, from one chamber side to the other .
13. Apparatus according to any one of the preceding claims , wherein the fluid delivery arrangement further comprises one or more conduits in fluid communication with a source for the chemical agent , one or each conduit extending to one or each respective aperture .
14. Apparatus according to claim 13 , wherein the conduits are one or more channels in a substrate that each extend to a respective aperture positioned in, or in relation to, the substrate .
15. Apparatus according to claim 14 , wherein the channels are as deep as the depth of view of the lowest magnification obj ective lenses and as wide as the width of the chamber .
16. Apparatus according to claim 15 , wherein the channels are 50μ in depth and 50μ in width .
17. Apparatus according to claim 16, wherein the apertures in the cell viewing surface are spaced at least 40μm apart .
18. Apparatus according to 13 , wherein one or each conduit is defined by a respective one or more micropipettes , with each aperture being defined by an outlet of the respective micropipette .
19. Apparatus according to any preceding claim wherein the one or more apertures is as wide as the width of the chamber and as narrow as 0.02μm.
20. Apparatus according to any preceding claim wherein the one or more aperture is lμm in diameter .
21. Apparatus according to any preceding claim wherein the chemical agent is delivered to the cell viewing surface under pressure .
22. Apparatus according to claim 20 wherein the chemical agent is delivered at a pressure of OhPa or more .
23. Apparatus according to claim 20 wherein the chemical agent is delivered at a pressure of 2OhPa .
24. Apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface , the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery arrangement to the cell viewing surface portion, the flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium.
25. Apparatus according to claim 21 , wherein the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
26. Apparatus according to claim 25 , wherein the one or each aperture has a configuration that influences a direction to the flow of chemical agent through the aperture .
27. Apparatus according to claim 25 or 26 , wherein the barrier construction is defined by a side wall of the one or each aperture, with each side wall influencing a direction to the flow of chemical agent through the aperture .
28. Apparatus according to claim 24 , wherein the barrier construction is defined by a dam in the chamber .
29. Apparatus according to claim 28 , wherein the dam is defined by a wall that subtends from the cell viewing surface in the chamber .
30. Apparatus according to any one of claims 24 to 29, wherein the fluid delivery arrangement is otherwise as defined in any one of claims 2 to 23.
31. A method for monitoring cell motility in response to a chemical agent in a medium, comprising the step of delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells , the chemical agent has assumed a concentration gradient in the medium.
32. A method according to claim 31 , wherein the concentration gradient of the chemical agent is assumed by physically directing the flow of chemical agent to the medium in the vicinity of the one or more cells .
33. A method according to claim 31 , wherein the flow of the chemical agent is physically directed through one or more apertures arranged in the medium.
34. A method according to claim 33 , wherein a side wall of one or each aperture physically directs the flow of the chemical agent through the aperture .
35. A method according to claim 31 , wherein the flow of chemical agent interacts with a barrier arranged in the fluid medium to physically direct the flow of the chemical agent .
36. A method according to claim 35 , wherein the barrier is defined by a dam.
37. A method according to any one of claims 31 to 36 that employs the apparatus as defined in any one of claims 1 to 27.
PCT/AU2006/000116 2005-01-31 2006-01-31 Apparatus and method for monitoring cell motility WO2006079185A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006208430A AU2006208430A1 (en) 2005-01-31 2006-01-31 Apparatus and method for monitoring cell motility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64808505P 2005-01-31 2005-01-31
US60/648,085 2005-01-31

Publications (1)

Publication Number Publication Date
WO2006079185A1 true WO2006079185A1 (en) 2006-08-03

Family

ID=36739987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2006/000116 WO2006079185A1 (en) 2005-01-31 2006-01-31 Apparatus and method for monitoring cell motility

Country Status (2)

Country Link
AU (1) AU2006208430A1 (en)
WO (1) WO2006079185A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008117192A1 (en) * 2007-03-26 2008-10-02 Koninklijke Philips Electronics N. V. A chemotaxis assay based on chemotactic agents releasing carrier structures
KR100896431B1 (en) 2007-05-31 2009-05-12 전자부품연구원 Method for testing reactivity of cancer cells to anti-cancer drug by analyzing their movability
US7594270B2 (en) 2004-12-29 2009-09-22 Alert Logic, Inc. Threat scoring system and method for intrusion detection security networks
WO2009121137A1 (en) * 2008-04-01 2009-10-08 Lilian Soon Method for imaging directional cell migration

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302515A (en) * 1992-08-20 1994-04-12 Neuro Probe, Inc. Chemotactic test apparatus and method
US5916801A (en) * 1996-10-31 1999-06-29 Lopinto; Richard William Nectophotometer
WO2000007007A1 (en) * 1998-07-28 2000-02-10 Biometric Imaging, Inc. Device and method for cell motility assay
US20030022269A1 (en) * 2000-11-08 2003-01-30 Gregory Kirk Method of monitoring cell motility and chemotaxis
WO2004053465A2 (en) * 2002-12-09 2004-06-24 Advanced Fluidix Laboratories, Llc Male fertility assay method and device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302515A (en) * 1992-08-20 1994-04-12 Neuro Probe, Inc. Chemotactic test apparatus and method
US5916801A (en) * 1996-10-31 1999-06-29 Lopinto; Richard William Nectophotometer
WO2000007007A1 (en) * 1998-07-28 2000-02-10 Biometric Imaging, Inc. Device and method for cell motility assay
US20030022269A1 (en) * 2000-11-08 2003-01-30 Gregory Kirk Method of monitoring cell motility and chemotaxis
WO2004053465A2 (en) * 2002-12-09 2004-06-24 Advanced Fluidix Laboratories, Llc Male fertility assay method and device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7594270B2 (en) 2004-12-29 2009-09-22 Alert Logic, Inc. Threat scoring system and method for intrusion detection security networks
WO2008117192A1 (en) * 2007-03-26 2008-10-02 Koninklijke Philips Electronics N. V. A chemotaxis assay based on chemotactic agents releasing carrier structures
KR100896431B1 (en) 2007-05-31 2009-05-12 전자부품연구원 Method for testing reactivity of cancer cells to anti-cancer drug by analyzing their movability
WO2009121137A1 (en) * 2008-04-01 2009-10-08 Lilian Soon Method for imaging directional cell migration

Also Published As

Publication number Publication date
AU2006208430A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
US20230182136A1 (en) In situ-generated microfluidic isolation structures, kits and methods of use thereof
CN101102847B (en) Microchannel separation cell using having patterned posts
US9592503B2 (en) System and method for performing droplet inflation
EP4039367A1 (en) System and method for isolating and analyzing cells
US20150064694A1 (en) Multidimensional hydrodynamic focusing chamber
US10471430B2 (en) Substrate for supporting liquid sample, an assembly comprising such a substrate and use thereof
JP2005509883A (en) Sample tip
US20070099292A1 (en) Reactor systems having a light-interacting component
CN104513787A (en) Integrated micro-fluidic chip and system for capture, culture and administration of single cells
US20080057561A1 (en) Cell culture treatment apparatus and cell culture treatment method
JP2015171379A (en) microfluidic particle analysis system
JP5263479B2 (en) Microchip
US8470110B2 (en) Sample chamber and method for the production thereof
WO2006079185A1 (en) Apparatus and method for monitoring cell motility
JP2006521786A5 (en)
JP2005536233A5 (en)
JP2010117197A (en) Microparticle dispenser and microparticle dispensing method
EP1509593A1 (en) Reactor systems having a light-interacting component
US20080254535A1 (en) Cell Separation Apparatus
US20230321659A1 (en) Microfluidic chip for high-throughput cell pairing and fusion
US20090035745A1 (en) Site-Specific Dosing of Cellular Cultures
WO2000035590A1 (en) Method of the dosed application of a liquid onto a surface
EP3639925A1 (en) Droplet generator and generation method
GB2621756A (en) Microfluidic chip, box body device, and microfluidic device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006208430

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006208430

Country of ref document: AU

Date of ref document: 20060131

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006208430

Country of ref document: AU

122 Ep: pct application non-entry in european phase

Ref document number: 06704798

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 6704798

Country of ref document: EP